Review article · 2026 · Open access

Evaluating the Association Between PPI Use and Dementia Risk Considering Methodological Choices: An Updated Meta‐Analysis

하헌영, Hyun Seok Lee, Jae‐Eun Park, Byoung Seok Ye, Yun Mi Yu, Young‐Mi Ah

Clinical Pharmacology & Therapeutics · Published 28 October 2026 · DOI 10.1002/cpt.70534

Open PDFView at the publisherCite this paper

In brief

“Evaluating the Association Between PPI Use and Dementia Risk Considering Methodological Choices: An Updated Meta‐Analysis” is a 2026 review article by 하헌영 and 5 co-authors, published in Clinical Pharmacology & Therapeutics. OpenAlex counts 0 citations as of 17 November 2026. It is open access: the full text is free to read at Clinical Pharmacology & Therapeutics.

Citations
0
References
74
Authors
6

Abstract

Proton pump inhibitors (PPIs), commonly prescribed for gastrointestinal disorders, have been investigated for their association with the risk of dementia. We aimed to assess the association between PPI use and dementia risk in older adults and examine the influence of methodological choices on this association. We conducted a meta-analysis of longitudinal observational studies, including subgroup analyses to address time-related biases and comparator selection. Relevant studies were systematically searched in the MEDLINE, Embase, and CENTRAL databases from their inception to January 25, 2026. Twenty-three studies of older adults without dementia at baseline, reporting adjusted estimates for PPI users versus a comparator group, met the inclusion criteria. The pooled hazard ratio (HR) indicated a modest association between PPI use and dementia (HR = 1.18, 95% confidence interval [CI] 1.02-1.37). Dementia risk did not differ significantly between PPI users and users of histamine-2 receptor antagonists (H2RAs) (HR = 1.04, 95% CI 0.89-1.20). In a post hoc analysis, H2RA use itself was associated with dementia (HR = 1.44, 95% CI 1.07-1.93), whereas excluding H2RA-treated patients strengthened the PPI estimate (HR = 1.75, 95% CI 1.38-2.22). Estimates also differed according to how time-related bias was handled: lag time, HR = 1.25, 95% CI 1.07-1.46; time-varying exposure, HR = 1.38, 95% CI 1.16-1.64. PPI use was modestly associated with incident dementia. However, the strength and specificity depended substantially on comparator selection and handling of time-related bias. Well-designed, long-term studies using active comparators are needed to clarify whether this effect is PPI-specific.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

하헌영, Lee, H. S., Park, J., Ye, B. S., Yu, Y. M., & Ah, Y. (2026). Evaluating the Association Between PPI Use and Dementia Risk Considering Methodological Choices: An Updated Meta‐Analysis. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70534

MLA 9

하헌영, et al. “Evaluating the Association Between PPI Use and Dementia Risk Considering Methodological Choices: An Updated Meta‐Analysis.” Clinical Pharmacology & Therapeutics, 2026. https://doi.org/10.1002/cpt.70534.

Chicago

하헌영, Hyun Seok Lee, Jae‐Eun Park, Byoung Seok Ye, Yun Mi Yu, and Young‐Mi Ah. 2026. “Evaluating the Association Between PPI Use and Dementia Risk Considering Methodological Choices: An Updated Meta‐Analysis.” Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70534.

Harvard

하헌영 et al. (2026) ‘Evaluating the Association Between PPI Use and Dementia Risk Considering Methodological Choices: An Updated Meta‐Analysis’, Clinical Pharmacology & Therapeutics. doi:10.1002/cpt.70534.

IEEE

하헌영, H. S. Lee, J. Park, B. S. Ye, Y. M. Yu, and Y. Ah, “Evaluating the Association Between PPI Use and Dementia Risk Considering Methodological Choices: An Updated Meta‐Analysis,” Clinical Pharmacology & Therapeutics, 2026, doi: 10.1002/cpt.70534.

BibTeX

@article{2026evaluating,
  title     = {{Evaluating the Association Between PPI Use and Dementia Risk Considering Methodological Choices: An Updated Meta‐Analysis}},
  author    = {하헌영 and Lee, Hyun Seok and Park, Jae‐Eun and Ye, Byoung Seok and Yu, Yun Mi and Ah, Young‐Mi},
  journal   = {Clinical Pharmacology \& Therapeutics},
  year      = {2026},
  doi       = {10.1002/cpt.70534},
  url       = {https://doi.org/10.1002/cpt.70534}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes

  • proton pump inhibitors
  • dementia risk
  • older adults
  • H2 receptor antagonists
  • time delay
  • time-varying exposure
  • comparator selection
  • incident dementia

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

하헌영, Lee, H. S., Park, J., Ye, B. S., Yu, Y. M., & Ah, Y. (2026). Evaluating the Association Between PPI Use and Dementia Risk Considering Methodological Choices: An Updated Meta‐Analysis. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70534

How many times has this paper been cited?

0 times, according to OpenAlex on 17 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Clinical Pharmacology & Therapeutics: sign in and open the PDF from this page.

Who wrote this paper?

하헌영, Hyun Seok Lee, Jae‐Eun Park, Byoung Seok Ye, Yun Mi Yu, Young‐Mi Ah.

What is the DOI of this paper?

10.1002/cpt.70534, permanently at https://doi.org/10.1002/cpt.70534. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 17 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.